Myelodysplastic syndrome following epipodophyllotoxin therapy in familial hemophagocytic lymphohistiocytosis.

Abstract

The prognosis for patients with familial hemophagocytic lymphohistiocytosis (FHL) is poor, but the survival of affected children has been markedly prolonged by treatment with the epipodophyllotoxin derivatives etoposide and teniposide and by bone marrow transplantation. Secondary malignancies following epipodophyllotoxin therapy, including myelodysplastic… (More)

Topics

Cite this paper

@article{Henter1993MyelodysplasticSF, title={Myelodysplastic syndrome following epipodophyllotoxin therapy in familial hemophagocytic lymphohistiocytosis.}, author={J Inge Henter and G{\"o}ran Elinder and P O L{\"u}beck and Anita Ost}, journal={Pediatric hematology and oncology}, year={1993}, volume={10 2}, pages={163-8} }